Literature DB >> 3104463

Induction, maintenance, and reinduction of tumoricidal activity in bone marrow-derived mononuclear phagocytes by Corynebacterium parvum. Evidence for the involvement of a T cell- and interferon-gamma-independent pathway of macrophage activation.

R Keller, R Keist, P H Van der Meide, P Groscurth, M Aguet, T P Leist.   

Abstract

Rat bone marrow-derived mononuclear phagocytes, virtually homogeneous with respect to the cell lineage, do not exhibit spontaneous tumoricidal activity in the resting state. When incubated with macrophage-activating lymphokines, rat recombinant interferon-gamma (IFN), or heat-killed Corynebacterium parvum, bone marrow-derived mononuclear phagocytes readily evolve tumoricidal activity. Whereas tumoricidal activity induced by lymphokines and/or rat recombinant IFN-gamma is short-lived, that elicited by C. parvum is maintained for at least 2 wk, provided that the C. parvum organisms are continuously present in the culture. After washing off extracellular organisms, C. parvum-induced tumoricidal activity decays rapidly, suggesting that sustained extracellular stimulation is required for its maintenance. Induction of tumoricidal activity by macrophage-activating lymphokines and/or rat recombinant IFN-gamma is fully prevented by polyclonal and monoclonal anti-IFN-gamma antibodies; in contrast, induction by C. parvum is not affected by anti-IFN-gamma. Since induction of tumoricidal activity by C. parvum takes place irrespective of the presence of anti-Thy-1 antisera or cyclosporin A, T cells and/or their products appear not to be involved in this type of macrophage activation. Accordingly, present findings provide evidence for the existence of lymphokine-independent pathways of macrophage activation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3104463

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  The macrophage response to bacteria. Modulation of macrophage functional activity by peptidoglycan from Moraxella (Branhamella) catarrhalis.

Authors:  R Keller; J E Gustafson; R Keist
Journal:  Clin Exp Immunol       Date:  1992-09       Impact factor: 4.330

2.  Gamma interferon treatment in vivo provokes accumulation of activated monocytes in the venous circulation of rats.

Authors:  B Steiniger; D Schröder; R Lück; L Luciano; P H van der Meide
Journal:  Am J Pathol       Date:  1990-04       Impact factor: 4.307

3.  Effect of anticancer drugs on the release of interferon gamma in vitro.

Authors:  K Ahmed; P H van der Meide; J L Turk
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

Review 4.  Cytotoxic effector cells of the immune system.

Authors:  P Groscurth
Journal:  Anat Embryol (Berl)       Date:  1989

5.  Kupffer cells and pit cells are not effective in the defense against experimentally induced colon carcinoma metastasis in rat liver.

Authors:  P Griffini; S M Smorenburg; I M Vogels; W Tigchelaar; C J Van Noorden
Journal:  Clin Exp Metastasis       Date:  1996-09       Impact factor: 5.150

6.  Involvement of reactive oxygen intermediates in tumor necrosis factor alpha-dependent bacteriostasis of Mycobacterium avium.

Authors:  A Sarmento; R Appelberg
Journal:  Infect Immun       Date:  1996-08       Impact factor: 3.441

7.  Antimicrobial properties of Kupffer cells.

Authors:  G A Filice
Journal:  Infect Immun       Date:  1988-06       Impact factor: 3.441

8.  Mononuclear phagocytes from human bone marrow progenitor cells; morphology, surface phenotype, and functional properties of resting and activated cells.

Authors:  R Keller; R Keist; P Joller; P Groscurth
Journal:  Clin Exp Immunol       Date:  1993-01       Impact factor: 4.330

9.  Effects of cytokines on intracellular growth of Brucella abortus.

Authors:  X Jiang; C L Baldwin
Journal:  Infect Immun       Date:  1993-01       Impact factor: 3.441

10.  Macrophage response to bacteria: induction of marked secretory and cellular activities by lipoteichoic acids.

Authors:  R Keller; W Fischer; R Keist; S Bassetti
Journal:  Infect Immun       Date:  1992-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.